Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 2/5 criteria met.
- ❌ Price trend failed
- ⚠️ Mixed growth
- ✅ Debt passed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2022 → 2023: 5.59%
Price change 2023 → 2024: -48.38%
Price change 2024 → 2025: -22.48%
Price change 2025 → 2026: -29.00%
Price change 2026 (year to date): -29.33%
Financial growth
Revenue CAGR (4 years): -0.11%
Earnings CAGR (4 years): 100.61%
Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.
Debt
Debt-to-equity ratio: 0.21
Debt/equity < 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 10.83
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 37.80% from the high over 6 months.
Excessive correction (> 20.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="SBC" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| SBC Medical Group Holdings Incorporated | 10.7 | 0.21 | −0.1 % | 🔒 |
| Figeac Aero S.A. | – | 4.83 | +10.2 % | – |
| Groupe CRIT S.A. | 13.9 | 0.28 | +6.5 % | – |
| Avax S.A. | 10.4 | 1.84 | +7.3 % | – |
| ME Group International plc | 7.7 | 0.20 | +2.4 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by SBC Medical Group Holdings Incorporated over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2022 | 174 m | 6.3 m | 3.6 % | n/a |
| 2023 | 194 m | 39.4 m | 20.3 % | +11.1 % |
| 2024 | 205 m | 46.6 m | 22.7 % | +6.1 % |
| 2025 | 174 m | 51.0 m | 29.4 % | -15.5 % |
Amounts converted to USD. Source: published annual accounts, collected on 13/11/2026.
Accounts and financial health
Balance sheet and cash flow published by SBC Medical Group Holdings Incorporated over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).
| Fiscal year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Cash and investments | 53.6 m | 103 m | 125 m | 164 m |
| Total Debt | 16.1 m | 22.9 m | 12.2 m | 51.6 m |
| Net Debt | -35.6 m | -80.2 m | -113 m | -112 m |
| Equity | 105 m | 142 m | 195 m | 248 m |
| Total assets | 225 m | 259 m | 266 m | 380 m |
| Operating cash flow | -47,369 | 50.6 m | 20.6 m | 24.7 m |
| Investments (capex) | 24.9 m | 9.5 m | 3.4 m | 2.8 m |
| Free cash-flow | -25.0 m | 39.4 m | 17.2 m | 22.3 m |
| Share buybacks | 0 | 0 | 0 | 5.0 m |
| Dividends paid | 0 | 0 | 0 | 0 |
Amounts in USD, currency of the published accounts.
Trailing 12-month ratios
Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 16/11/2026.
Valuation and competitors
SBC Medical Group Holdings Incorporated compared with its sector on the same exchange and with its main competitors.
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 12/11/2026. Competitors: comparable companies named by the data provider.
Dividends and earnings
SBC Medical Group Holdings Incorporated: dividend history, last distributions, stock splits and earnings releases.
No known dividend for this company.
Earnings releases
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 13/08/2026 | 0.10 | 0.12 | -13.9 % |
| 14/05/2026 | 0.11 | 0.10 | +10.0 % |
| 27/03/2026 | 0.14 | 0.13 | +7.7 % |
| 14/11/2025 | 0.12 | 0.13 | -7.7 % |
| 13/08/2025 | 0.02 | 0.14 | -85.7 % |
| 15/05/2025 | 0.21 | 0.11 | +90.9 % |
Factual data: ex-dividend history and earnings calendar, as of 15/11/2026. A past dividend does not guarantee the next one.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about SBC Medical Group Holdings Incorporated
What is the SBC Medical Group Holdings Incorporated share price?
Latest recorded price: 7.35 USD on 13/11/2026, for a market cap of 756 m USD.
What is the revenue of SBC Medical Group Holdings Incorporated?
174 m USD for fiscal year 2025, with net income of 51.0 m USD (net margin 29.4 %).
What is the P/E ratio of SBC Medical Group Holdings Incorporated?
Trailing 12-month P/E of 15.6, against 12.4 for the sector median on the same exchange (10-year median: 24.3).
Is SBC Medical Group Holdings Incorporated stock eligible for the French PEA?
No: the company is headquartered outside the European Union and the European Economic Area (ISIN US73245B1070).
How many employees does SBC Medical Group Holdings Incorporated have?
863 full-time employees according to the latest published profile.
Who runs SBC Medical Group Holdings Incorporated?
Yoshiyuki Aikawa is the company's chief executive.